Imunon (NASDAQ: IMNN) awards director 6,180 shares for board fees

Rhea-AI Filing Summary

Braun Donald P reported acquisition or exercise transactions in this Form 4 filing.

Imunon, Inc. director Donald P. Braun received a grant of 6,180 shares of common stock on July 31, 2026 at $1.59 per share, issued in lieu of cash for a portion of his board fees. Following this award, he directly holds 15,499 shares.

Insider Trade Summary

Net Buyer: 6,180 shares

Net Buy 1 txn

Insider Braun Donald P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	6,180	$1.59	$10K

Holdings After Transaction: Common Stock — 15,499 shares (Direct)

Footnotes (1)

1. F1. Stock granted in lieu of cash for portion of board fees

Key Figures

Shares awarded: 6,180 shares of Common Stock Grant price per share: $1.59 per share Shares held after transaction: 15,499 shares +1 more

4 metrics

Shares awarded 6,180 shares of Common Stock Non-derivative equity award to director Donald P. Braun on July 31, 2026

Grant price per share $1.59 per share Reported value used for the 6,180-share stock grant

Shares held after transaction 15,499 shares Total direct Imunon common stock holdings for Donald P. Braun after the award

Transaction date 2026-07-31 Date of the reported stock grant to Donald P. Braun

Key Terms

Common Stock, Grant, award, or other acquisition, in lieu of cash, board fees

4 terms

Common Stock financial

"security_title: "Common Stock" for the non-derivative transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

in lieu of cash financial

"Stock granted in lieu of cash for portion of board fees"

board fees financial

"Stock granted in lieu of cash for portion of board fees"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 04:14 PM Accepted by SEC EDGAR 08/04/2026 - 04:14 PM Learn about SEC filing dates

FAQ

What stock grant did Imunon (IMNN) director Donald P. Braun report?

Donald P. Braun was granted 6,180 Imunon common shares at $1.59 per share. The shares were issued as compensation, specifically in lieu of cash for a portion of his board fees, and represent an equity-based element of his director remuneration.

How many Imunon (IMNN) shares does Donald P. Braun hold after this Form 4 transaction?

After the reported grant, Donald P. Braun directly holds 15,499 Imunon shares. This total reflects his position following receipt of 6,180 shares granted on July 31, 2026 as partial payment of his board fees in stock instead of cash.

Was the Imunon (IMNN) stock grant to Donald P. Braun a market purchase?

No, the 6,180 Imunon shares were granted as compensation, not bought on the market. A footnote explains the stock was granted in lieu of cash for a portion of Braun’s board fees, making this a non-derivative, award-type acquisition.

What was the implied value per share of Donald P. Braun’s Imunon (IMNN) grant?

The grant was reported at an implied value of $1.59 per Imunon share. This per-share figure is used to report the value of the 6,180-share award that Braun received as stock compensation for part of his service on the company’s board.

What type of transaction code was used in Donald P. Braun’s Imunon (IMNN) Form 4?

The transaction used code “A,” described as a grant, award, or other acquisition. This indicates the 6,180 Imunon common shares were received as a compensatory equity award rather than through an open-market purchase or sale, and are held directly by Braun.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Braun Donald P

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NEW JERSEY 08648

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2026		A		6,180(1)	A	$1.59	15,499	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Stock granted in lieu of cash for portion of board fees

	/s/ Susan Eylward, Attorney-in-Fact for Donald P. Braun	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)